Potential Neuroendocrine Disruption by Benzodiazepines and Its Impact on Male Fertility

Neuroactive substances have emerged as potent endocrine disruptors affecting male reproductive health through central and peripheral mechanisms. Among these, benzodiazepines, which are widely used for the management of anxiety, insomnia, epilepsy, and neuromuscular disorders, are known as GABA A (gamma-aminobutyric acid type A) receptor positive allosteric modulators. These are traditionally believed to have central nervous system effects. However, recent experimental findings suggest that benzodiazepines may have peripheral effects through testicular homeostasis and the hypothalamic-pituitary-gonadal axis. This article aims to present an overview of experimental and clinical studies focusing on the potential harmful effects of benzodiazepines on male reproductive health, particularly concerning pharmacokinetics and neuroendocrine, cellular, and hormonal mechanisms Benzodiazepines have lipophilic characteristics, which means they remain longer in tissues and membranes, allowing them to accumulate in reproductive organs, which also have a lipophilic environment. Sustained modulation of inhibitory neural signaling may disrupt gonadotropin release, decrease testosterone synthesis, and impair testicular signaling pathways, ultimately compromising spermatogenesis. Some animal and in vitro studies suggest testicular changes, reduced testosterone levels, impaired sperm motility, and increased oxidative stress in reproductive cells. These changes may arise due to chronic exposure to benzodiazepines. Although some human studies are limited, the detection of benzodiazepines in seminal fluid and the association of drug use with altered sperm parameters remain under investigation in male reproductive health. Other studies indicate that benzodiazepines may also function as neuroendocrine disruptors, primarily impairing male fertility through central and peripheral mechanisms. However, further human studies are needed to understand the risks, the reversibility of the drug's effects, and the potential generational impacts. Well-designed longitudinal research is essential to determine dose dependency, reversibility, and possible transgenerational consequences of chronic benzodiazepine exposure.